Endodontic surgery with and without inserts of bioactive glass PerioGlas®: a clinical and radiographic follow-up
2009 (English)In: Oral and maxillofacial surgery, ISSN 1865-1569, Vol. 13, no 1, 21-26 p.Article in journal (Refereed) Published
OBJECTIVE: This study evaluated the use of bioactive glass, PerioGlas, after retrograde filling with Super EBA cement in the treatment of periapical bone destruction.
STUDY DESIGN: Healing outcomes were followed up after endodontic surgery in 186 teeth. Outcomes were divided into two groups according to follow-up time: short- and long-term. The EBA group (n = 110) underwent endodontic surgery and retrograde filling with EBA cement. In the EBA + PerioGlas group (n = 76), PerioGlas was embedded in the bone cavity after retrograde filling.
RESULTS: The success rate in the EBA + PerioGlas group was 72% compared with 56% in the Super EBA group at the short-term follow-up and 74% and 84%, respectively, at the long-term follow-up. Healing of periapical bone destruction classified as uncertain at the short-term follow-up was considered successful in two out of three cases at the long-term follow-up.
CONCLUSION: This study found that PerioGlas as bone substitute did not significantly improve endodontic healing outcome.
Place, publisher, year, edition, pages
2009. Vol. 13, no 1, 21-26 p.
Bone graft evaluation, Bone regeneration, Endodontic surgery, PerioGlas®, Retrograde filling
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:uu:diva-153492DOI: 10.1007/s10006-008-0141-5PubMedID: 19023604OAI: oai:DiVA.org:uu-153492DiVA: diva2:416999